Hvilken er prisen på LumiraDx Limited (LMDX)

Prisen på LumiraDx Limited (LMDX) er $0.016

Hva er markedsverdien på LumiraDx Limited (LMDX)

Markedsverdien på LumiraDx Limited (LMDX) er $5.10M

LumiraDx Limited (LMDX) Fortjeneste per Aksje

LumiraDx Limited is a prominent provider of point-of-care diagnostic solutions. Its core mission is to revolutionize community healthcare by equipping medical professionals with crucial diagnostic insights directly at the patient's side. The company develops and commercializes a sophisticated diagnostic platform, offering a diverse array of tests that deliver laboratory-grade performance directly at the point of care. With approximately 30 tests either commercially available or under development, their comprehensive portfolio addresses critical conditions such as infectious diseases, cardiovascular disorders, diabetes, and coagulation issues. Furthermore, they offer a full suite of COVID-19 testing solutions, adaptable for both laboratory environments and immediate point-of-need applications. These diagnostic tools are widely adopted by governments and healthcare institutions, deployed in diverse settings including traditional laboratories, urgent care clinics, physician's offices, pharmacies, schools, and workplaces. Their applications span screening, diagnosis, and monitoring for both general wellness and specific diseases. Established in 2014, the company's headquarters are located in London, United Kingdom.

År	EPS	Endre
Ikke nok data for de angitte datoene.

År

EPS

Endre

Ikke nok data for de angitte datoene.

Selskap	EPS	EPS-forskjell	Land
Thermo Fisher Scientific Inc. TMO.US	$18.62	-	US
Danaher Corporation DHR.US	$5.65	-	US
WuXi AppTec Co., Ltd. 603259.SS	-	-	CN
Natera, Inc. NTRA.US	$-1.36	-	US
IDEXX Laboratories, Inc. IDXX.US	$14.24	-	US

Selskap

EPS

EPS-forskjell

Land